Krebs Biochemicals Industries Ltd vs Medico Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 57.85 as of 15 May 15:30 . The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Medico Remedies Ltd changed from 16 on March 2021 to 42.7 on March 2025 . This represents a CAGR of 21.69% over 5 years The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 174.33 crore on March 2021 to ₹ 144 crore on March 2025 . This represents a CAGR of -3.75% over 5 yearsThe Market Cap of Medico Remedies Ltd changed from ₹ 41.49 crore on March 2021 to ₹ 432.35 crore on March 2025 . This represents a CAGR of 59.80% over 5 years The revenue of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 7.28 crore as compare to the Sep '25 revenue of ₹ 4.17 crore. This represent the growth of 74.58% The revenue of Medico Remedies Ltd for the Dec '25 is ₹ 59.36 crore as compare to the Sep '25 revenue of ₹ 54.36 crore. This represent the growth of 9.2% The ebitda of Krebs Biochemicals & Industries Ltd for the Dec '25 is ₹ 0.3 crore as compare to the Sep '25 ebitda of ₹ -2.79 crore. This represent the decline of -110% The ebitda of Medico Remedies Ltd for the Dec '25 is ₹ 5.01 crore as compare to the Sep '25 ebitda of ₹ 4.44 crore. This represent the growth of 12.84% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -5.17 crore to ₹ -3.13 crore over 7 quarters. This represents a CAGR of -24.93% The net profit of Medico Remedies Ltd changed from ₹ 1.58 crore to ₹ 2.87 crore over 7 quarters. This represents a CAGR of 40.65% The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Medico Remedies Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.

About Medico Remedies Ltd

Medico Remedies Limited was incorporated as a Private Limited Company as 'Medico Remedies Private Limited' on March 18, 1994.
The status was changed to a Public Company and the name of the Company was changed to Medico Remedies Limited on March 6, 2017. Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements.
Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

FAQs for the comparison of Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd

Which company has a larger market capitalization, Krebs Biochemicals & Industries Ltd or Medico Remedies Ltd?

Market cap of Krebs Biochemicals & Industries Ltd is 120 Cr while Market cap of Medico Remedies Ltd is 370 Cr

What are the key factors driving the stock performance of Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd?

The stock performance of Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd?

As of May 18, 2026, the Krebs Biochemicals & Industries Ltd stock price is INR ₹55.71. On the other hand, Medico Remedies Ltd stock price is INR ₹44.6.

How do dividend payouts of Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd compare?

To compare the dividend payouts of Krebs Biochemicals & Industries Ltd and Medico Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.